Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele; D. A. Breems; G. Stuessi; Y. van Norden; M. Bargetzi; B. J. Biemond; P. A von dem Borne; Y. Chalandon; J. Cloos; D. Deeren; M. Fehr; B. T. Gjertsen; C. Graux; G. Huls; J. J.W.M. Janssen; A. Jaspers; M. Jongen-Lavrencic; E. de Jongh; S. K. Klein; M. van der Klift; M. van Marwijk Kooy; J. A. Maertens; L. Michaux; M. W.M. van der Poel; A. Van Rhenen; L. Tick; P. Valk; M. C. Vekemans; W. J.F.M. van der Velden; O. de Weerdt; T. Pabst; M. Manz; B. Löwenberg; D. A. Breems; Havelange; M. C. Vekemans; I. Moors; F. van Obberg; J. A. Maertens; B. Hodossy; S. Vansteenweghen; L. Lammertijn; D. Deeren; S. K. Klein; J. J.W.M. Janssen; R. E. Brouwer; H. C. Schouten; O. de Weerdt; J. Kuball; A. Van Rhenen

doi:10.1038/s41375-020-0994-7

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele
, D. A. Breems
, G. Stuessi
, Y. van Norden
, M. Bargetzi
, B. J. Biemond
, P. A von dem Borne
, Y. Chalandon
, J. Cloos
, D. Deeren
, M. Fehr
, B. T. Gjertsen
, C. Graux
, G. Huls
, J. J.W.M. Janssen
, A. Jaspers
, M. Jongen-Lavrencic
, E. de Jongh
, S. K. Klein
, M. van der Klift

M. van Marwijk Kooy, J. A. Maertens, L. Michaux, M. W.M. van der Poel, A. Van Rhenen, L. Tick, P. Valk, M. C. Vekemans, W. J.F.M. van der Velden, O. de Weerdt, T. Pabst, M. Manz, B. Löwenberg, D. A. Breems, Havelange, M. C. Vekemans, I. Moors, F. van Obberg, J. A. Maertens, B. Hodossy, S. Vansteenweghen, L. Lammertijn, D. Deeren, S. K. Klein, J. J.W.M. Janssen, R. E. Brouwer, H. C. Schouten, O. de Weerdt, J. Kuball, A. Van Rhenen,

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Correction to: Leukemia

https://doi.org/10.1038/s41375-020-0725-0

Original language	English
Pages (from-to)	2820-2820
Number of pages	1
Journal	Leukemia
Volume	34
Issue number	10
DOIs	https://doi.org/10.1038/s41375-020-0994-7
Publication status	Published - 1 Oct 2020

Access to Document

10.1038/s41375-020-0994-7

s41375-020-0994-7Final published version, 222 KBLicence: Taverne

Cite this

Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. W. M., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K. (2020). Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, 34(10), 2820-2820. https://doi.org/10.1038/s41375-020-0994-7

@article{8dc10ef7a33c4d72920f5e9aa4b1933c,

title = "Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS",

abstract = "Correction to: Leukemiahttps://doi.org/10.1038/s41375-020-0725-0",

author = "Ossenkoppele, \{G. J.\} and Breems, \{D. A.\} and G. Stuessi and \{van Norden\}, Y. and M. Bargetzi and Biemond, \{B. J.\} and \{A von dem Borne\}, P. and Y. Chalandon and J. Cloos and D. Deeren and M. Fehr and Gjertsen, \{B. T.\} and C. Graux and G. Huls and Janssen, \{J. J.W.M.\} and A. Jaspers and M. Jongen-Lavrencic and \{de Jongh\}, E. and Klein, \{S. K.\} and \{van der Klift\}, M. and \{van Marwijk Kooy\}, M. and Maertens, \{J. A.\} and L. Michaux and \{van der Poel\}, \{M. W.M.\} and \{Van Rhenen\}, A. and L. Tick and P. Valk and Vekemans, \{M. C.\} and \{van der Velden\}, \{W. J.F.M.\} and \{de Weerdt\}, O. and T. Pabst and M. Manz and B. L{\"o}wenberg and Breems, \{D. A.\} and Havelange and Vekemans, \{M. C.\} and I. Moors and \{van Obberg\}, F. and Maertens, \{J. A.\} and B. Hodossy and S. Vansteenweghen and L. Lammertijn and D. Deeren and Klein, \{S. K.\} and Janssen, \{J. J.W.M.\} and Brouwer, \{R. E.\} and Schouten, \{H. C.\} and \{de Weerdt\}, O. and J. Kuball and \{Van Rhenen\}, A.",

year = "2020",

month = oct,

day = "1",

doi = "10.1038/s41375-020-0994-7",

language = "English",

volume = "34",

pages = "2820--2820",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "10",

}

Ossenkoppele, GJ, Breems, DA, Stuessi, G, van Norden, Y, Bargetzi, M, Biemond, BJ, A von dem Borne, P, Chalandon, Y, Cloos, J, Deeren, D, Fehr, M, Gjertsen, BT, Graux, C, Huls, G, Janssen, JJWM, Jaspers, A, Jongen-Lavrencic, M, de Jongh, E, Klein, SK, van der Klift, M, van Marwijk Kooy, M, Maertens, JA, Michaux, L, van der Poel, MWM, Van Rhenen, A, Tick, L, Valk, P, Vekemans, MC, van der Velden, WJFM, de Weerdt, O, Pabst, T, Manz, M, Löwenberg, B, Breems, DA, Havelange, Vekemans, MC, Moors, I, van Obberg, F, Maertens, JA, Hodossy, B, Vansteenweghen, S, Lammertijn, L, Deeren, D, Klein, SK, Janssen, JJWM, Brouwer, RE, Schouten, HC, de Weerdt, O, Kuball, J, Van Rhenen, A 2020, 'Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS', Leukemia, vol. 34, no. 10, pp. 2820-2820. https://doi.org/10.1038/s41375-020-0994-7

TY - JOUR

T1 - Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

AU - Ossenkoppele, G. J.

AU - Breems, D. A.

AU - Stuessi, G.

AU - van Norden, Y.

AU - Bargetzi, M.

AU - Biemond, B. J.

AU - A von dem Borne, P.

AU - Chalandon, Y.

AU - Cloos, J.

AU - Deeren, D.

AU - Fehr, M.

AU - Gjertsen, B. T.

AU - Graux, C.

AU - Huls, G.

AU - Janssen, J. J.W.M.

AU - Jaspers, A.

AU - Jongen-Lavrencic, M.

AU - de Jongh, E.

AU - Klein, S. K.

AU - van der Klift, M.

AU - van Marwijk Kooy, M.

AU - Maertens, J. A.

AU - Michaux, L.

AU - van der Poel, M. W.M.

AU - Van Rhenen, A.

AU - Tick, L.

AU - Valk, P.

AU - Vekemans, M. C.

AU - van der Velden, W. J.F.M.

AU - de Weerdt, O.

AU - Pabst, T.

AU - Manz, M.

AU - Löwenberg, B.

AU - Breems, D. A.

AU - Havelange,

AU - Vekemans, M. C.

AU - Moors, I.

AU - van Obberg, F.

AU - Maertens, J. A.

AU - Hodossy, B.

AU - Vansteenweghen, S.

AU - Lammertijn, L.

AU - Deeren, D.

AU - Klein, S. K.

AU - Janssen, J. J.W.M.

AU - Brouwer, R. E.

AU - Schouten, H. C.

AU - de Weerdt, O.

AU - Kuball, J.

AU - Van Rhenen, A.

PY - 2020/10/1

Y1 - 2020/10/1

N2 - Correction to: Leukemiahttps://doi.org/10.1038/s41375-020-0725-0

AB - Correction to: Leukemiahttps://doi.org/10.1038/s41375-020-0725-0

UR - https://www.scopus.com/pages/publications/85088783180

U2 - 10.1038/s41375-020-0994-7

DO - 10.1038/s41375-020-0994-7

M3 - Comment/Letter to the editor

AN - SCOPUS:85088783180

SN - 0887-6924

VL - 34

SP - 2820

EP - 2820

JO - Leukemia

JF - Leukemia

IS - 10

ER -

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Abstract

Access to Document

Other files and links

Fingerprint

Cite this